Bremers E, Butler J, Do Amaral L, Merino E, Almolhim H, Zhou B
ACS Infect Dis. 2025; 11(2):529-542.
PMID: 39808111
PMC: 11828674.
DOI: 10.1021/acsinfecdis.4c01001.
Anam Z, Kumari G, Mukherjee S, Rex D, Biswas S, Maurya P
Front Cell Infect Microbiol. 2022; 12:924424.
PMID: 36250062
PMC: 9556994.
DOI: 10.3389/fcimb.2022.924424.
Pedra-Rezende Y, Macedo I, Midlej V, Mariante R, Menna-Barreto R
Front Microbiol. 2022; 13:856686.
PMID: 35422792
PMC: 9002357.
DOI: 10.3389/fmicb.2022.856686.
Osei S, Biney R, Obese E, Agbenyeku M, Attah I, Ameyaw E
Malar J. 2021; 20(1):113.
PMID: 33632233
PMC: 7908739.
DOI: 10.1186/s12936-021-03658-6.
Efange N, Lobe M, Keumoe R, Ayong L, Efange S
Sci Rep. 2020; 10(1):17932.
PMID: 33087791
PMC: 7578093.
DOI: 10.1038/s41598-020-74824-0.
Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents.
Van de Walle T, Boone M, Van Puyvelde J, Combrinck J, Smith P, Chibale K
Eur J Med Chem. 2020; 198:112330.
PMID: 32408064
PMC: 7294232.
DOI: 10.1016/j.ejmech.2020.112330.
Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
Richards S, Nash M, Baker E, Webster M, Lehane A, Shafik S
PLoS Pathog. 2016; 12(7):e1005725.
PMID: 27441371
PMC: 4956231.
DOI: 10.1371/journal.ppat.1005725.
An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.
Siwo G, Smith R, Tan A, Button-Simons K, Checkley L, Ferdig M
BMC Genomics. 2015; 16:1030.
PMID: 26637195
PMC: 4670519.
DOI: 10.1186/s12864-015-2165-1.
Asparagine requirement in Plasmodium berghei as a target to prevent malaria transmission and liver infections.
Nagaraj V, Mukhi D, Sathishkumar V, Subramani P, Ghosh S, Pandey R
Nat Commun. 2015; 6:8775.
PMID: 26531182
PMC: 4659947.
DOI: 10.1038/ncomms9775.
PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.
van der Velden M, Rijpma S, Russel F, Sauerwein R, Koenderink J
Malar J. 2015; 14:76.
PMID: 25884516
PMC: 4350286.
DOI: 10.1186/s12936-015-0581-y.
Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites.
Munkhjargal T, AbouLaila M, Terkawi M, Sivakumar T, Ichikawa M, Davaasuren B
Am J Trop Med Hyg. 2012; 87(4):681-8.
PMID: 22890034
PMC: 3516319.
DOI: 10.4269/ajtmh.2012.12-0218.
Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.
Griffin C, Hoke J, Samarakoon U, Duan J, Mu J, Ferdig M
Antimicrob Agents Chemother. 2012; 56(10):5356-64.
PMID: 22869567
PMC: 3457399.
DOI: 10.1128/AAC.05667-11.
Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.
Lelievre J, Almela M, Lozano S, Miguel C, Franco V, Leroy D
PLoS One. 2012; 7(4):e35019.
PMID: 22514702
PMC: 3325938.
DOI: 10.1371/journal.pone.0035019.
Antischistosomal activities of mefloquine-related arylmethanols.
Ingram K, Ellis W, Keiser J
Antimicrob Agents Chemother. 2012; 56(6):3207-15.
PMID: 22470113
PMC: 3370792.
DOI: 10.1128/AAC.06177-11.
Additive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1,10-phenanthroline derivatives and cysteine protease inhibitor e64.
Wijayanti M, Sholikhah E, Hadanu R, Jumina J, Supargiyono S, Mustofa M
Malar Res Treat. 2012; 2010:540786.
PMID: 22332022
PMC: 3275986.
DOI: 10.4061/2010/540786.
Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.
Summers R, Nash M, Martin R
Cell Mol Life Sci. 2012; 69(12):1967-95.
PMID: 22286067
PMC: 11115045.
DOI: 10.1007/s00018-011-0906-0.
Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum.
Poyomtip T, Suwandittakul N, Sitthichot N, Khositnithikul R, Tan-Ariya P, Mungthin M
Malar J. 2012; 11:7.
PMID: 22221394
PMC: 3287963.
DOI: 10.1186/1475-2875-11-7.
Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura P, Dame J, Fidock D
Antimicrob Agents Chemother. 2009; 53(12):4968-78.
PMID: 19752273
PMC: 2786340.
DOI: 10.1128/AAC.00882-09.
Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis.
de Villiers K, Egan T
Molecules. 2009; 14(8):2868-87.
PMID: 19701131
PMC: 6254801.
DOI: 10.3390/molecules14082868.
Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.
Roberts L, Egan T, Joiner K, Hoppe H
Antimicrob Agents Chemother. 2008; 52(5):1840-2.
PMID: 18316523
PMC: 2346632.
DOI: 10.1128/AAC.01478-07.